Catalog Number 326666 |
Device Problem
Unsealed Device Packaging (1444)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/18/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that prior to use with bd ultra-fine¿ 1/2ml insulin syringe one unit was discovered to not be in the unit packaging, thus affecting sterility.The following information was provided by the initial reporter, translated from japanese to english: one polybag of product (32666) was not packaged.
|
|
Manufacturer Narrative
|
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that prior to use with bd ultra-fine¿ 1/2ml insulin syringe one unit was discovered to not be in the unit packaging, thus affecting sterility.The following information was provided by the initial reporter, translated from japanese to english: one polybag of product (32666) was not packaged.
|
|
Manufacturer Narrative
|
H6: investigation summary no samples were returned therefore the investigation was performed based on the photos provided.The customer returned three photos of the 0.5ml, 29-gauge bd syringe polybag.The customer reported torn polybag.The photos were examined and exhibited an open polybag across the top of the pouch.A review of the device history record was completed for batch# 2171563.All inspections and challenges were performed per the applicable operations qc specifications.Based on the photos received, embecta was able to confirm the customer¿s indicated failure (polybag damaged/torn).There were no quality notifications or dispatches that pertained to the complaint; therefore, no root cause can be determined.
|
|
Search Alerts/Recalls
|